4.2 Combining SM6Met with tamoxifen in a ratio of 20:1 inhibited all three processes implicated in ER+ breast cancer progression and metastasis to a significantly greater degree than 4-OH-Tam alone. This evidence concerns the gene ESR1 and breast carcinoma.